4Gob CS ,Poland RE. MDMA. In Lowinson J H ,Ruiz P,Millnam RB, Langrob J G. Eds. substance abuse . 3^rd.Baltimore , Williams wilkins ; 1997.269 - 270.
5WHO. Amphetamine -type stimulants: A report from meeting on amphetamine, MDMA and other psychostimulants . Geneva , 12 - 15 NOV . 1996 . Geneva ,WHO ;1997:94-97.
6McCann UD , Scheffel U , et al . positron emission tomographic evidence of toxic effect of MDMA (ecstasy) on brain serologic neurons in humans beings . Lancet m1998,352 : 1433 - 143.
7Cohen RS . subjective reports on the effects of the MDMA (ecstasy) experience in humans. Prog Neuropsychopharmacol. Boil psychiatry m1995,19 : 1137 - 1145.
8Colado Mi , O' Shea E , Granados R , et al . studies on the role of dopamine in the degeneration of 5 - HT nerve endings in the brain of Dark Agouti rats following 3,4 -methylenesioxymethamphetamine ( MDMA or "ecstasy" )administration Br J pharmacol, 1999,126:911 - 924.
9Colado Mi ,O' Shea E ,Esteban B ,et al ,studies on the neuroprotective effect of the enantiomers of AR -A008055, a compound structuuuuuuuuuurally related to clomethiazole , on MDMA ( ' ecstasy' ) - induced neurodefeneration in rat brain psychopharmacolofy (Berl) ,2001,157:82 -88.
